logo-loader
Bushveld Minerals Limited

Bushveld Minerals shares jump as SP Angel maintains 'buy' rating and hikes target price

Bushveld stands to benefit from an expected increase in vanadium prices as demand outstrips demand, according to SP Angel

Vanadium
Vanadium prices have surged 137% over the past year

Bushveld Minerals Limited PLC (LON:BMN) shares shot higher on Monday as SP Angel maintained a ‘buy’ rating on the vanadium miner and hiked its target price to 87p from 37p.

SP Angel noted that vanadium prices have jumped in China and Europe due to a shortage of available material.

READ: Bushveld Minerals pushes ahead with Vametco expansion as vanadium prices rise again

“We are struggling to see how the market may supply demand for vanadium in the next two years and we feel vanadium prices should settle at a higher price level than previously envisaged for the longer term,” the broker said.

SP Angel expects demand to outstrip supply, pushing up ferro-vanadium prices to US$85 per kilogram (kg) for 2018, 2019 and 2020 and to US$55 per kg for 2021 and US$45 per kg for 2022 and thereafter.

Bushveld owns a 74% stake in Vametco, a vanadium open pit mine in South Africa. 

In an update last week, Bushveld said it would push ahead with the expansion of its Vametco vanadium plant to take advantage of soaring demand for the steel additive.

Vanadium prices increased 24% over the quarter to September to US$85.8/Kg and have risen by 137% over the past 12 months.

“Our valuation for Bushveld Minerals rises to US$1.6bn assuming an 8% discount rate and a long-term exchange rate of ZAR14/USD or 90p/s on our new vanadium price and production rate assumptions,” SP Angel said.

“We assume production rises to 10,000 tonnes per annum in 2023.”

Shares jumped 6.1% to 43.50p in late morning trading. 

 

Quick facts: Bushveld Minerals Limited

Price: £0.22

Market: LSE
Market Cap: £240.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bushveld Minerals Limited named herein, including the promotion by the Company of Bushveld Minerals Limited in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: hVIVO’s mosquito vaccine moves into the clinic

Headlines from the Proactive Investors UK newsroom.  Clinical services group hVIVO’s (LON:HVO) experimental vaccine AGS-v PLUS is to undergo a phase 1 safety trial at the University of Maryland school of medicine. The vaccine is designed to protect against mosquito-borne diseases such as...

2 weeks, 5 days ago

2 min read